Belite Bio Inc ADR (BLTE) Financials

$160.66

$3.96 (2.53%)

As on 02-Sep-2026 16:00EDT

Market cap

$6,110 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

8.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	0.45	0.40	0.20	0.03
Gross Profit	--	--	-0.45	-0.40	-0.20	-0.03
Operating Expenses	118.69	84.21	40.00	31.67	12.82	9.80
Operating Profit (EBIT)	-118.69	-84.21	-40.00	-31.67	-12.82	-9.80
Other Income	--	--	--	--	--	--
Profit before Tax	-102.31	-77.61	-36.14	-31.62	-12.65	-9.67
Provision for Tax	0.06	--	0.01	0.01	-0.17	0.13
Profit after Tax (Net Income)	-102.36	-77.61	-36.14	-31.63	-12.65	-9.67
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-9.67

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	--	770.49	145.82	90.43	41.50	-15.09
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.19	0.26	0.58	0.67	31.81
Current Liabilities	--	9.88	6.05	3.63	2.10	1.64
Total Liabilities	--	780.56	152.13	94.64	44.27	18.35

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	286.28	5.06	4.70	1.47	0.92
Current Assets	--	494.27	147.07	89.94	42.81	17.43
Total Assets	--	780.56	152.13	94.64	44.27	18.35
Total Debt*	--	0.43	0.54	0.89	0.87	31.81
Net Current Assets	--	484.39	141.02	86.31	40.70	15.80

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-36.99	-29.23	-29.84	-11.46	-7.47
Cash Flow from Investing Activities	--	-305.11	-110.57	-0.06	-0.39	-0.06
Cash from Financing Activities	--	663.23	83.60	75.96	36.96	-0.58
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.79	-2.31	-1.15	-1.12	-0.61	-1.01
Cash EPS ($)	--	-2.30	-1.13	-1.10	-0.60	-1.01
Adjusted Book Value ($)	--	22.97	4.64	3.19	2.01	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.10	-0.93	-1.05	-0.55	-0.78
Free Cash Flow per Share ($)	--	-1.11	-0.93	-1.06	-0.57	-0.79

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-16.92	-30.41	-47.32	-42.82	-46.60
ROE (%)	-26.57	-16.94	-30.60	-47.95	-95.79	87.36
ROA (%)	-66.60	-16.64	-29.29	-45.54	-40.40	-43.85
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	39.52	-114.88	-14.30	-150.14	-30.68	-68.31
Net Profit Growth (%)	-107.32	-114.73	-14.26	-150.09	-30.85	-68.02
EPS Growth (%)	-80.07	-1.01	-0.03	-0.82	0.39	-0.55
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-69.12	-54.91	-40.95	-49.22	--
Price / Book Value	8.18	6.96	13.61	14.33	15.00	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-35.61	-63.16	-51.59	-38.73	-46.75	--
Close Price ($)	153.99	159.96	63.10	45.75	30.15	--
High Price ($)	200.00	169.75	86.53	46.70	44.70	--
Low Price ($)	56.10	49.00	31.01	11.00	6.00	--
Market Cap ($ Cr)	6,110.09	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.00	0.01	0.02	-2.11
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	--
Current Ratio	--	50.02	24.31	24.76	20.35	10.66
Quick Ratio	--	--	--	--	20.35	--
Interest Coverage	--	-38,805.50	-1,805.90	-1,263.92	-789.50	-1,933.20

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-17.39	-35.05	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.